Healthcare & Life Sciences

Orbus Therapeutics

series-a
series-a
Stage
1
Investors

About

Developing therapeutics for rare cancers, including anaplastic astrocytoma.

Explore Orbus Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.